Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy With Rituximab in HIV-Related B-Cell Non-Hodgkin's Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01193842
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:27.806031+00:00
Published At
2018-06-12T00:00:00+00:00
Record Updated At
2023-11-21
Results Posted At
2018-06-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["AIDS-Related Plasmablastic Lymphoma", "AIDS-Related Primary Effusion Lymphoma", "Ann Arbor Stage I Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage I Grade 3 Follicular Lymphoma", "Ann Arbor Stage II Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma", "Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma", "Ann Arbor Stage III Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage III Grade 3 Follicular Lymphoma", "Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage IV Grade 3 Follicular Lymphoma", "HIV Infection", "Plasmablastic Lymphoma", "Primary Effusion Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Grade 3 Follicular Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-21"
protocolSection.identificationModule.nctId
"NCT01193842"
protocolSection.identificationModule.officialTitle
"A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy With Rituximab in HIV-Related B-Cell Non-Hodgkin\u0027s Lymphoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-06-12"

Study condition terms

  • AIDS-Related Plasmablastic Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-Related Primary Effusion Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage I Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage I Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage III Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage IV Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • HIV Infection (protocolSection.conditionsModule.conditions)
  • Plasmablastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Effusion Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.